Literature DB >> 9894524

[Clinical relevance of thoracic CT in intensive care and emergency medicine].

M Gartenschläger1, F Schweden, C Düber, L S Weilemann, S Ott, T Westermeier, M Thelen.   

Abstract

PURPOSE: Evaluation of the impact, indications, and therapeutic efficiency of chest CT in intensive-care and emergency patients.
MATERIALS AND METHODS: Retrospective assessment of 741 consecutive chest CT, or which 74% were acquired in the spiral technique, in intensive-care and emergency patients. Chest CT scans and respective clinical data were compared.
RESULTS: 16% of all examinations were indicated to resolve questions arising from the chest radiogram, 10% to confirm or exclude pulmonary embolisms and 10% to confirm or exclude aortic dissection. In 10% a focus of infection was sought. 57% of all CT examinations had an impact on therapy, in 7% further diagnostic tests were prompted. Among a total of 588 clinical decisions based upon chest CT, the most frequent therapeutic conclusions consisted in: minimally invasive CT guided interventions in 17%. A new drug was administered in 13%, surgical intervention was performed in 13%, bed-side interventions such as insertion of a drainage tube in 13%, and a given pharmacological therapy was continued in 11%.
CONCLUSION: Chest CT has a strong impact on patient management in emergency and critical-care medicine. CT guided interventions are frequently used in critically-ill patients. The introduction of the spiral technique has led to important new CT indications in the field of non-invasive vascular diagnosis, namely the assessment of pulmonary embolism and aortic dissection.

Entities:  

Mesh:

Year:  1998        PMID: 9894524

Source DB:  PubMed          Journal:  Aktuelle Radiol        ISSN: 0939-267X


  1 in total

1.  Portable computed tomography performed on the intensive care unit.

Authors:  Ulf K M Teichgräber; Jens Pinkernelle; Jan-Steffen Jürgensen; Jens Ricke; Udo Kaisers
Journal:  Intensive Care Med       Date:  2003-01-24       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.